SHSE:603235 (China)
Â
Class A
Â¥
27.44
(+2.96%)
Apr 30
Business Description
JiangXi Tianxin Pharmaceutical Co Ltd
ISIN : CNE100005Q89
Share Class Description:
SHSE:603235: Class ACompare
Compare
Traded in other countries / regions
603235.China IPO Date
2022-07-12Description
JiangXi Tianxin Pharmaceutical Co Ltd is engaged in the research and development, production and sales of monomeric vitamin products.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 21.31 | |||||
| Equity-to-Asset | 0.83 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | 0.19 | |||||
| Interest Coverage | 10.53 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 10.26 | |||||
| Beneish M-Score | -2.82 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -9.6 | |||||
| 3-Year EBITDA Growth Rate | -17.8 | |||||
| 3-Year EPS without NRI Growth Rate | -24.2 | |||||
| 3-Year FCF Growth Rate | -41.2 | |||||
| 3-Year Book Growth Rate | 48.9 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 84.59 | |||||
| 9-Day RSI | 76.98 | |||||
| 14-Day RSI | 72.49 | |||||
| 6-1 Month Momentum % | -12.05 | |||||
| 12-1 Month Momentum % | -21.93 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.77 | |||||
| Quick Ratio | 5.73 | |||||
| Cash Ratio | 5 | |||||
| Days Inventory | 130.53 | |||||
| Days Sales Outstanding | 45.69 | |||||
| Days Payable | 31.68 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.59 | |||||
| Dividend Payout Ratio | 0.64 | |||||
| Forward Dividend Yield % | 2.59 | |||||
| 5-Year Yield-on-Cost % | 2.66 | |||||
| 3-Year Average Share Buyback Ratio | -3.6 | |||||
| Shareholder Yield % | 3.28 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 38.27 | |||||
| Operating Margin % | 24.81 | |||||
| Net Margin % | 25.29 | |||||
| FCF Margin % | 10.29 | |||||
| ROE % | 11.49 | |||||
| ROA % | 9.85 | |||||
| ROIC % | 17.38 | |||||
| ROC (Joel Greenblatt) % | 31.17 | |||||
| ROCE % | 12.63 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 25.24 | |||||
| PE Ratio without NRI | 24.83 | |||||
| PS Ratio | 6.39 | |||||
| PB Ratio | 2.85 | |||||
| Price-to-Tangible-Book | 2.97 | |||||
| Price-to-Free-Cash-Flow | 62.52 | |||||
| Price-to-Operating-Cash-Flow | 16.49 | |||||
| EV-to-EBIT | 16.69 | |||||
| EV-to-EBITDA | 16.69 | |||||
| EV-to-Revenue | 5.03 | |||||
| EV-to-FCF | 48.9 | |||||
| Price-to-Graham-Number | 1.81 | |||||
| Price-to-Net-Current-Asset-Value | 5.31 | |||||
| Price-to-Net-Cash | 8.29 | |||||
| Earnings Yield (Greenblatt) % | 5.99 | |||||
| FCF Yield % | 1.61 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
JiangXi Tianxin Pharmaceutical Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,881.993 | ||
| EPS (TTM) (Â¥) | 1.09 | ||
| Beta | 0 | ||
| Volatility % | 33.19 | ||
| 14-Day RSI | 72.49 | ||
| 14-Day ATR (Â¥) | 0.959615 | ||
| 20-Day SMA (Â¥) | 24.289 | ||
| 12-1 Month Momentum % | -21.93 | ||
| 52-Week Range (Â¥) | 19.13 - 32.46 | ||
| Shares Outstanding (Mil) | 437.78 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
JiangXi Tianxin Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
JiangXi Tianxin Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
JiangXi Tianxin Pharmaceutical Co Ltd Frequently Asked Questions
What is JiangXi Tianxin Pharmaceutical Co Ltd(SHSE:603235)'s stock price today?
The current price of SHSE:603235 is ¥27.44. The 52 week high of SHSE:603235 is ¥32.46 and 52 week low is ¥19.13.
When is next earnings date of JiangXi Tianxin Pharmaceutical Co Ltd(SHSE:603235)?
The next earnings date of JiangXi Tianxin Pharmaceutical Co Ltd(SHSE:603235) is .
Does JiangXi Tianxin Pharmaceutical Co Ltd(SHSE:603235) pay dividends? If so, how much?
The Dividend Yield %  of JiangXi Tianxin Pharmaceutical Co Ltd(SHSE:603235) is 2.59% (As of Today), Highest Dividend Payout Ratio of JiangXi Tianxin Pharmaceutical Co Ltd(SHSE:603235) was 0.72. The lowest was 0.64. And the median was 0.72. The  Forward Dividend Yield % of JiangXi Tianxin Pharmaceutical Co Ltd(SHSE:603235) is 2.59%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers